Utah State Patent of the Month (June 2026): Stand-Alone Interbody Fusion by Nexus Spine

The medical technology landscape continues to advance rapidly, marked by a major milestone in spinal healthcare innovation. Nexus Spine, LLC has officially secured the Utah State Patent of the Month for June 2026 for their revolutionary new development, “Stand-alone interbody fusion.”

This groundbreaking invention, filed under U.S. Patent No. 12,616,585, introduces a novel method for stabilizing spinal implants using unique, deployable internal anchors. By eliminating the necessity for traditional, bulky supplementary fixation plates and complex external instrumentation, this technology establishes a less invasive approach to modern orthopedic surgery.

Why the Stand-Alone Interbody Fusion Patent is So Innovative

Traditional spinal fusion procedures generally depend on external hardware, such as anterior cervical plates, rods, or extensive posterior pedicle screws, to ensure that an interbody cage remains stable while bone healing takes place. These additional systems significantly increase surgical complexity, prolong time spent in the operating room, and require a larger surgical exposure corridor. A larger corridor often results in heightened postoperative pain, extensive muscle disruption, and a greater overall risk of hardware failure or adjacent segment degeneration.

Nexus Spine solves this long-standing clinical dilemma by integrating the fixation mechanism directly inside the implant core. The device features one or more deployable spikes or anchors designed to remain nested, collapsed, or fully retracted while the surgeon inserts the implant into the human body. Once the cage is properly positioned within the intervertebral disc space, the surgeon deploys these anchors directly outward into the adjacent vertebral bone. This seamless, inline deployment securely anchors the implant’s position against unwanted migration or subsidence. This approach maintains proper disc height and provides immediate rigid stability without needing any extra-profile external hardware.

Why It Won Utah State Patent of the Month for June 2026

Headquartered in Draper, Utah, Nexus Spine has consistently demonstrated leadership in the orthopedic field by applying the principles of compliant mechanisms to spinal implants. Following the official issuance of U.S. Patent No. 12,616,585 in May 2026, the selection committee recognized this technology as the June 2026 Patent of the Month due to its outstanding clinical utility and engineering brilliance. By turning a complex spinal reconstruction into a streamlined, standalone procedure, this design minimizes patient morbidity, decreases hospital stay lengths, and cuts overall healthcare costs. This achievement highlights Utah’s position as a premier global hub for transformative medical device engineering.

U.S. R&D Tax Credit Eligibility for Practical Applications

The practical engineering and development efforts required to bring this patented standalone design to fruition offer an ideal pathway for Nexus Spine to claim the U.S. Research and Development (R&D) Tax Credit under IRC Section 41. To qualify, the development activities must satisfy the statutory four-part test, which this spinal implant readily meets. The engineering team actively worked to eliminate technical uncertainties concerning the structural integrity, deployment mechanics, and long-term reliability of the nested anchors under cyclical physiological loads. Through an iterative process of experimentation, the company utilized advanced biomechanical engineering and materials science to prototype, model, and evaluate different geometric configurations of the deployable spikes. The rigorous testing conducted to maximize osteointegration and verify that anchor deployment does not fracture fragile vertebral endplates qualifies associated expenditures, such as employee wages, consultant fees, and prototype material costs, as Qualified Research Expenses (QREs) to yield substantial tax incentives.